Prise en charge de l’œdème maculaire secondaire à une occlusion veineuse rétinienne

[1]  T. Wong,et al.  Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion. , 2014, American journal of ophthalmology.

[2]  P. Campochiaro,et al.  Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. , 2014, Ophthalmology.

[3]  U. Schmidt-Erfurth,et al.  Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO Study. , 2014, Ophthalmology.

[4]  T. Hikichi,et al.  Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion , 2013, British Journal of Ophthalmology.

[5]  Bernd Junker,et al.  Efficacy and Safety of Intravitreal Therapy in Macular Edema Due to Branch and Central Retinal Vein Occlusion: a Systematic Review , 2013, PloS one.

[6]  K. Lindsley,et al.  Anti-vascular endothelial growth factor for neovascular glaucoma. , 2013, The Cochrane database of systematic reviews.

[7]  Mathias Maier,et al.  Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6‐month follow‐up – The SOLO study , 2013, Acta ophthalmologica.

[8]  Dan Lindfield,et al.  Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-needed , 2013, British Journal of Ophthalmology.

[9]  A. Kampik,et al.  Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion , 2013, Eye.

[10]  P. Campochiaro,et al.  Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion. , 2013, Ophthalmology.

[11]  J. Haller,et al.  Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. , 2013, American journal of ophthalmology.

[12]  Y. Ogura,et al.  VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study , 2013, British Journal of Ophthalmology.

[13]  A. Loewenstein,et al.  Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion , 2013, Eye.

[14]  S. Seregard,et al.  Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study. , 2012, Ophthalmology.

[15]  M. Parodi,et al.  Compassionate use of dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion in a clinical setting , 2012, Acta ophthalmologica.

[16]  E. Tutar,et al.  Effect on anterior chamber bevacizumab injection combined with seton implantation in treatment of rubeosis iridis in Neovascular Glaucoma , 2012, Cutaneous and ocular toxicology.

[17]  J. Haller,et al.  Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study. , 2012, Ophthalmology.

[18]  P. Campochiaro,et al.  Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. , 2012, Ophthalmology.

[19]  M. Parodi,et al.  Rebound effect after intravitreal dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[20]  J. Vander,et al.  Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study , 2012 .

[21]  J. F. Arevalo,et al.  Ranibizumab for serous macular detachment in branch retinal vein occlusions , 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.

[22]  Seung-Young Yu,et al.  Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion , 2011, Ophthalmologica.

[23]  I. Georgalas,et al.  Recurrence of macular edema in retinal vein occlusions after treatment with intravitreal ranibizumab (Lucentis). , 2011, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[24]  M. Blumenkranz,et al.  Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. , 2011, Ophthalmology.

[25]  R. Avery,et al.  INTRAVITREAL RANIBIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION , 2011, Retina.

[26]  J. Slakter,et al.  LONGER-TERM OUTCOMES OF A PROSPECTIVE STUDY OF INTRAVITREAL RANIBIZUMAB AS A TREATMENT FOR DECREASED VISUAL ACUITY SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION , 2011, Retina.

[27]  J. Vander,et al.  Antagonism of Vascular Endothelial Growth Factor for Macular Edema Caused by Retinal Vein Occlusions: Two-Year Outcomes , 2011 .

[28]  S. Hayreh,et al.  Natural history of visual outcome in central retinal vein occlusion. , 2011, Ophthalmology.

[29]  Allen C Ho,et al.  Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. , 2011, Ophthalmology.

[30]  Gabriel Coscas,et al.  Hemodilution therapy using automated erythrocytapheresis in central retinal vein occlusion: results of a multicenter randomized controlled study , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.

[31]  P. Campochiaro,et al.  Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes. , 2010, Ophthalmology.

[32]  J. Seland,et al.  Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC study. , 2010, American journal of ophthalmology.

[33]  S. Piermarocchi,et al.  Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up , 2010, British Journal of Ophthalmology.

[34]  Sarah Gray,et al.  Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.

[35]  M. Blumenkranz,et al.  Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. , 2010, Ophthalmology.

[36]  P. Campochiaro,et al.  Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.

[37]  I. Ladas,et al.  INTRAVITREAL RANIBIZUMAB (LUCENTIS) FOR BRANCH RETINAL VEIN OCCLUSION-INDUCED MACULAR EDEMA: Nine-Month Results of a Prospective Study , 2010, Retina.

[38]  I. Ladas,et al.  Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[39]  J. Slakter,et al.  Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. , 2009, American journal of ophthalmology.

[40]  H. Quiroz-Mercado,et al.  RADIAL OPTIC NEUROTOMY FOR CENTRAL RETINAL VEIN OCCLUSION: Results of the Pan-American Collaborative Retina Study Group (PACORES) , 2008, Retina.

[41]  C. Nguyen,et al.  Treatment of Central Retinal Vein Occlusion-Related Macular Edema with Intravitreal Bevacizumab (Avastin®): Preliminary Results , 2008, Klinische Monatsblatter fur Augenheilkunde.

[42]  Sharon D. Solomon,et al.  Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[43]  R. Avery,et al.  Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions. , 2007, Ophthalmology.

[44]  Richard F Spaide,et al.  Early bevacizumab treatment of central retinal vein occlusion. , 2007, American journal of ophthalmology.

[45]  M. Maia,et al.  Intravitreal Bevacizumab (Avastin(R)) for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: Results of the Pan-American Collaborative Retina Study Group (PACORES) , 2007 .

[46]  S. Takeuchi,et al.  Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion. , 2004, American journal of ophthalmology.

[47]  R. Spaide,et al.  RETINAL CHOROIDAL COLLATERAL CIRCULATION AFTER RADIAL OPTIC NEUROTOMY CORRELATED WITH THE LESSENING OF MACULAR EDEMA , 2004, Retina.

[48]  R. Feist,et al.  Sheathotomy to decompress branch retinal vein occlusion: a matched control study. , 2004, Ophthalmology.

[49]  F. Shiraga,et al.  Evaluation of arteriovenous crossing sheathotomy for branch retinal vein occlusion by fluorescein videoangiography and image analysis. , 2003, American journal of ophthalmology.

[50]  C. Pournaras,et al.  Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[51]  P. Kaiser,et al.  The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion , 2003, The British journal of ophthalmology.

[52]  V. Martinez-Castillo,et al.  Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion. , 2003, Archives of ophthalmology.

[53]  E. Opremcak,et al.  RADIAL OPTIC NEUROTOMY FOR CENTRAL RETINAL VEIN OCCLUSION: A Retrospective Pilot Study of 11 Consecutive Cases , 2001, Retina.

[54]  S. Saika,et al.  Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[55]  G. Brown,et al.  Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion. , 2000, American journal of ophthalmology.

[56]  R A Bruce,et al.  Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. , 1999, Retina.

[57]  David J. Wilson,et al.  Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. , 1995, Ophthalmology.

[58]  M. Wiederholt,et al.  A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. , 1989, The British journal of ophthalmology.

[59]  M. Reim,et al.  Hemodilution therapy in central retinal vein occlusion One-year results of a prospective randomized study , 2022 .